1 序文
2 調査範囲と方法論
2.1 調査の目的
2.2 ステークホルダー
2.3 データソース
2.3.1 一次情報源
2.3.2 二次情報源
2.4 市場推定
2.4.1 ボトムアップアプローチ
2.4.2 トップダウンアプローチ
2.5 予測方法
3 エグゼクティブ・サマリー
4 はじめに
4.1 概要
4.2 主要業界動向
5 世界のトラベルワクチン市場
5.1 市場概要
5.2 市場パフォーマンス
5.3 COVID-19の影響
5.4 成分別市場構成
5.5 疾患別市場構成比
5.6 地域別市場構成比
5.7 市場予測
6 組成別市場構成
6.1 モノワクチン
6.1.1 市場動向
6.1.2 市場予測
6.2 混合ワクチン
6.2.1 市場動向
6.2.2 市場予測
7 疾患別市場内訳
7.1 A型肝炎
7.1.1 市場動向
7.1.2 市場予測
7.2 DPT
7.2.1 市場動向
7.2.2 市場予測
7.3 黄熱
7.3.1 市場動向
7.3.2 市場予測
7.4 腸チフス
7.4.1 市場動向
7.4.2 市場予測
7.5 B型肝炎
7.5.1 市場動向
7.5.2 市場予測
7.6 麻疹・流行性耳下腺炎
7.6.1 市場動向
7.6.2 市場予測
7.7 狂犬病
7.7.1 市場動向
7.7.2 市場予測
7.8 髄膜炎菌
7.8.1 市場動向
7.8.2 市場予測
7.9 水痘
7.9.1 市場動向
7.9.2 市場予測
7.10 日本脳炎
7.10.1 市場動向
7.10.2 市場予測
7.11 その他
7.11.1 市場動向
7.12.2 市場予測
8 地域別市場内訳
8.1 北米
8.1.1 市場動向
8.1.2 市場予測
8.2 欧州
8.2.1 市場動向
8.2.2 市場予測
8.3 アジア太平洋
8.3.1 市場動向
8.3.2 市場予測
8.4 中東・アフリカ
8.4.1 市場動向
8.4.2 市場予測
8.5 中南米
8.5.1 市場動向
8.5.2 市場予測
9 世界のトラベルワクチン産業SWOT分析
9.1 概要
9.2 強み
9.3 弱点
9.4 機会
9.5 脅威
10 世界のトラベルワクチン産業バリューチェーン分析
10.1 探索段階
10.2 前臨床および臨床開発
10.3 薬事承認
10.4 製造
10.5 マーケティングと流通
11 世界のトラベルワクチン産業ポーターズファイブフォース分析
11.1 概要
11.2 買い手の交渉力
11.3 供給者の交渉力
11.4 競争の程度
11.5 新規参入の脅威
11.6 代替品の脅威
12 世界のトラベルワクチン産業価格分析
13 旅行用ワクチンの製造工程
13.1 製品概要
13.2 原材料要件
13.3 製造工程
13.4 主な成功要因とリスク要因
14 競争環境
14.1 市場構造
14.2 主要プレーヤー
14.3 主要企業のプロフィール
14.3.1 グラクソ・スミスクライン・ファーマシューティカルズ・リミテッド
14.3.2 サノフィ・パスツール
14.3.3 メルク・アンド・カンパニー・インク
14.3.4 ノバルティスAG
14.3.5 ファイザー株式会社
14.3.6 ALK-Abelló A/S
14.3.7 バイエルン ノルディック A/S
14.3.8 クルーセル（ジョンソン・エンド・ジョンソンの子会社）
14.3.9 CSLリミテッド
14.3.10 アストラゼネカPLC
14.3.11 アルティミューン社
14.3.12 アボット・ラボラトリーズ
14.3.13 ホフマン・ラ・ロシュ社
図1：世界：旅行用ワクチン市場：主な推進要因と課題
図2：世界：トラベルワクチン市場：販売額（単位：億ドル）、2019年-2024年
図3：世界：トラベルワクチン市場構成比（%）、2024年
図4: 旅行用ワクチンの世界市場:疾患別構成比(%), 2024年疾患別構成比（%）、2024年
図5：トラベルワクチンの世界市場：疾患別構成比（%）、2024年地域別構成比（%）、2024年
図6：トラベルワクチンの世界市場予測：販売額（単位：億ドル）、2025年-2033年
図7: 世界: 旅行用ワクチン産業：SWOT分析
図8: 世界: 旅行用ワクチン産業：バリューチェーン分析
図9: 世界: 旅行用ワクチン産業：ポーターのファイブフォース分析
図10: 世界のトラベルワクチン（単独ワクチン）市場：販売額（単位：百万ドル）、2019年および2024年
図11: 世界のトラベルワクチン（単独ワクチン）市場予測：販売額（百万ドル）、2025年～2033年
図12：トラベルワクチン（混合ワクチン）の世界市場：売上金額（単位：百万USドル販売額（百万ドル）、2019年および2024年
図13：トラベルワクチン（混合ワクチン）の世界市場予測：販売額（百万ドル）、2025年～2033年
図14: 旅行用ワクチン（A型肝炎）の世界市場：売上金額（単位：百万USドル販売額（百万ドル）、2019年・2024年
図15：世界のトラベルワクチン（A型肝炎）市場予測：販売額（単位：百万米ドル）、2025年〜2033年
図16: 旅行用ワクチン（DPT）の世界市場：売上金額（単位：百万USドル販売額（百万ドル）、2019年および2024年
図17: 旅行用ワクチン（DPT）の世界市場予測：販売額（百万ドル）、2025年～2033年
図18: 旅行用ワクチン（黄熱）の世界市場：売上金額（単位：百万USドル販売額（百万ドル）、2019年および2024年
図19：トラベルワクチン（黄熱）の世界市場予測：販売額（百万ドル）、2025年～2033年
図20: 旅行用ワクチン（腸チフス）の世界市場：販売額（単位：百万USドル販売額（百万ドル）、2019年および2024年
図21：トラベルワクチン（腸チフス）の世界市場予測：販売額（百万ドル）、2025年～2033年
図22: 旅行用ワクチン（B型肝炎）の世界市場：売上金額（単位：百万USドル販売額（百万ドル）、2019年・2024年
図23：トラベルワクチン（B型肝炎）の世界市場予測：販売額（単位：百万USドル）、2025年〜2033年
図24: 世界の旅行用ワクチン（麻疹、おたふく風邪）市場：販売額（単位：百万USドル販売額（単位：百万USドル）、2019年・2024年
図25：世界：トラベルワクチン（麻疹、おたふく風邪）市場予測：販売額（単位：百万ドル）、2025年〜2033年
図26：世界：トラベルワクチン（狂犬病）市場：販売額（百万ドル）、2019年および2024年
図27：世界：トラベルワクチン（狂犬病）市場予測：販売額（百万ドル）、2025年～2033年
図28：世界：トラベルワクチン（髄膜炎菌）市場：販売額（百万ドル）、2019年および2024年
図29：世界：トラベルワクチン（髄膜炎菌）市場予測：販売額（単位：百万ドル）、2025年～2033年
図30：世界：トラベルワクチン（水痘）市場：販売額（単位：百万USドル）、2019年および2024年
図31：世界：トラベルワクチン（水痘）市場予測：販売額（単位：百万USドル）、2025年〜2033年
図32：世界：トラベルワクチン（日本脳炎）市場：販売額（百万ドル）、2019年および2024年
図33：世界：トラベルワクチン（日本脳炎）市場予測：販売額（単位：百万USドル）、2025年～2033年
図34：世界：トラベルワクチン（その他）市場：販売額（百万ドル）、2019年および2024年
図35：世界：トラベルワクチン（その他）市場予測：販売額（百万米ドル）、2025年〜2033年
図36：北米：旅行用ワクチントラベルワクチン市場販売額（百万米ドル）、2019年および2024年
図37：北米：旅行用ワクチン市場予測トラベルワクチン市場の予測：販売額（単位：百万米ドル）、2025年～2033年
図38：欧州: 旅行用ワクチンの市場予測: 2025-2033トラベルワクチン市場：販売額（単位：百万米ドル）、2019年および2024年
図39：ヨーロッパ：旅行用ワクチン市場予測トラベルワクチン市場の予測：販売額（単位：百万米ドル）、2025年～2033年
図40：アジア太平洋：トラベルワクチン市場：販売額（単位：百万米ドル）、2019年および2024年
図41：アジア太平洋地域: 旅行用ワクチン市場予測旅行用ワクチンの市場予測：販売額（単位：百万米ドル）、2025年～2033年
図42：中東およびアフリカ：トラベルワクチン市場：販売額（単位：百万米ドル）、2019年および2024年
図43：中東およびアフリカ：トラベルワクチン市場の予測：販売額（単位：百万米ドル）、2025年～2033年
図44：中南米: 旅行用ワクチンの市場予測: 2025-2033トラベルワクチン市場：販売額（単位：百万米ドル）、2019年および2024年
図45：中南米: 旅行用ワクチンの市場予測: 2019年および2024年トラベルワクチン市場の予測：販売額（単位：百万米ドル）、2025年～2033年
図46：トラベルワクチンの製造：プロセスフロー
表一覧
表1：世界：トラベルワクチン市場：主要産業ハイライト、2024年と2033年
表2：世界：トラベルワクチン市場予測：構成別内訳（単位：百万ドル）、2025年〜2033年
表3：トラベルワクチンの世界市場予測：疾病別構成比（単位：百万ドル）、2025-2033年
表4：トラベルワクチンの世界市場予測：地域別構成比（単位：百万ドル）、2025-2033年
表5: 旅行用ワクチン：原材料所要量
表6：トラベルワクチンの世界市場構造
表7：世界：トラベルワクチン市場：主要プレイヤー
The global travel vaccines market size reached USD 4.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 10.0 Billion by 2033, exhibiting a growth rate (CAGR) of 9.36% during 2025-2033. The market is experiencing steady growth driven by the escalating demand for exotic and off-the-beaten-path travel experiences, government initiatives to provide free travel vaccinations to their citizens as part of public health programs, and changing disease patterns and emerging threats.
Travel Vaccines Market Analysis:
Market Growth and Size: The market is witnessing strong growth, which can be attributed to increasing international travel activities. In addition, the rising awareness among the masses about travel-related diseases is bolstering the market growth.
Technological Advancements: Innovations in vaccine development, such as the introduction of more convenient and effective formulations, is ensuring better protection for travelers.
Industry Applications: Travel vaccines are crucial for both leisure and business travelers, as they offer protection against various diseases.
Geographical Trends: North America leads the market, on account of its strong emphasis on health and safety during travel. However, Europe is emerging as a fast-growing market, driven by its diverse range of destinations and a large number of international travelers.
Competitive Landscape: Key players in the market are actively engaged in strategic initiatives. They are investing in research and development (R&D) activities to expand their vaccine portfolios, addressing emerging travel-related health risks, and enhancing existing efficacy of vaccines.
Challenges and Opportunities: While the market faces challenges, such as vaccine hesitancy and regulatory hurdles, it also encounters opportunities in expanding vaccine accessibility and tailored vaccine solutions for specific regions.
Future Outlook: The future of the travel vaccines market looks promising, with ongoing research and development (R&D) activities in vaccine production. Moreover, the adoption of digital health solutions for pre-travel consultations is expected to propel the growth of the market.
Travel Vaccines Market Trends:
Rising international travel
The increasing international travel among the masses around the world is supporting the growth of the market. As globalization and accessibility to travel are growing, the risk of exposure to infectious diseases in various parts of the world is rising. Travelers are venturing to destinations with varying healthcare standards and disease prevalence, making vaccinations a crucial precaution. This trend is further bolstered by the growth of leisure travel, business travel, and international students studying abroad. Moreover, the desire for exotic and off-the-beaten-path travel experiences is leading individuals to explore regions with unique health risks, emphasizing the need for specialized vaccines. The growing awareness among individuals about health precautions while traveling is underscoring the importance of vaccines for international travelers, which is offering a favorable market outlook.
Government initiatives and regulations
Government initiatives and regulations play a pivotal role in driving the market. Many countries are recognizing the importance of safeguarding public health and preventing the spread of diseases through international travel. As a result, governing agencies of several countries are implementing stringent regulations and recommendations regarding travel vaccinations. These regulations often mandate certain vaccinations for travelers entering or exiting their borders, especially for destinations with known disease risks. The International Health Regulations (IHR) by the World Health Organization (WHO) require proof of yellow fever vaccination for travelers visiting certain countries. Additionally, some governments offer subsidized or free travel vaccinations to their citizens as part of public health programs. These regulations and initiatives not only create a legal requirement for travelers but also raise awareness about the necessity of travel vaccines, driving demand in the market.
Global disease outbreaks and pandemics
Global disease outbreaks and pandemics have a profound impact on driving the market. These events are encouraging travelers and governments, highlighting the potential health risks associated with international travel. In response to such outbreaks, there is an escalating demand for vaccines that can protect against specific infectious diseases prevalent in certain regions. Disease outbreaks and pandemics are leading to the development and distribution of vaccines to mitigate the spread of the virus and facilitate safe travel. Travelers are becoming more conscious about the need for vaccinations to protect themselves and others, leading to greater adoption of travel vaccines. Governments and international health organizations also emphasize the importance of vaccines as a key tool in preventing and controlling outbreaks, encouraging travelers to be vaccinated before embarking on their journeys.
Changing disease patterns and emerging threats
The dynamic nature of disease patterns and the emergence of new infectious threats are strengthening the growth of the market. Infectious diseases are not static, they evolve, mutate, and spread to new regions. This ever-changing landscape necessitates ongoing research and development (R&D) activities of vaccines to combat evolving pathogens. Diseases like Zika virus and Ebola are emerging as significant concerns for travelers in recent years, prompting the development of specific vaccines to address these threats. This awareness of changing disease patterns, along with the ease of accessing information, is encouraging individuals to seek protection through vaccinations before embarking on their journeys.
Travel Vaccines Industry Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global and regional levels for 2025-2033. Our report has categorized the market based on composition and disease.
Breakup by Composition:
Mono Vaccines
Combination Vaccines
Combination vaccines account for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the composition. This includes mono vaccines and combination vaccines. According to the report, combination vaccines represented the largest segment.
Combination vaccines offer the convenience of protecting against multiple diseases with a single injection. Popular combination vaccines include those that guard against hepatitis A and B, as well as typhoid. The primary advantage of combination vaccines is their efficiency in providing comprehensive protection, simplifying the vaccination process for travelers. This convenience is especially appealing to individuals who plan to visit regions with multiple disease risks, reducing the number of shots required. The combination vaccines segment is growing due to increased demand for streamlined vaccination regimens and improved compliance among travelers seeking a one-shot solution for their health needs.
Mono vaccines consist of individual vaccines targeting specific diseases. These vaccines are designed to provide protection against a single infectious agent, such as hepatitis A, hepatitis B, or typhoid. Mono vaccines are often recommended when travelers are visiting regions with a particularly high risk of one specific disease. They offer the advantage of targeted protection, allowing travelers to customize their vaccination regimen based on their destination and individual health needs.
Breakup by Disease:
Hepatitis A
DPT
Yellow Fever
Typhoid
Hepatitis B
Measles and Mumps
Rabies
Meningococcal
Varicella
Japanese Encephalitis
Others
Hepatitis A represents the leading market segment
The report has provided a detailed breakup and analysis of the market based on the disease. This includes hepatitis A, DPT, yellow fever, typhoid, hepatitis B, measles and mumps, rabies, meningococcal, varicella, Japanese encephalitis, and others. According to the report, hepatitis A represented the largest segment.
Hepatitis A is a highly contagious viral infection that can be contracted through contaminated food or water, making it a significant concern for travelers. This segment includes vaccines that provide immunity against the hepatitis A virus. Due to its prevalence in many travel destinations, hepatitis A vaccination is recommended for individuals traveling to regions with inadequate sanitation and hygiene standards. The prominence of hepatitis A in the market reflects the widespread recognition of its risk and the importance of vaccination for the health and safety of travelers.
DPT vaccines, which protect against diphtheria, pertussis (whooping cough), and tetanus, are another important segment in the travel vaccines market. While these diseases are not exclusive to travel-related risks, they are included in some international vaccination recommendations. Tetanus can be a concern if travelers are exposed to contaminated wounds during their journeys. Therefore, DPT vaccines are essential for ensuring comprehensive protection against these preventable diseases, even when traveling.
Yellow fever vaccines target the prevention of yellow fever, a mosquito-borne viral disease prevalent in certain tropical regions. Travelers visiting countries in Africa and South America where yellow fever is endemic often require proof of vaccination for entry. The yellow fever segment in the travel vaccines market serves travelers who plan to explore these high-risk areas and need to adhere to international health regulations.
Typhoid vaccines are essential for travelers heading to regions with a higher risk of typhoid fever, often linked to contaminated food and water sources. These vaccines protect against Salmonella typhi, the bacterium responsible for typhoid fever. The typhoid segment addresses the specific health needs of travelers venturing to areas with suboptimal sanitation and hygiene conditions.
Hepatitis B vaccines are important for travelers who may engage in activities that carry an elevated risk of exposure to the hepatitis B virus, such as unprotected sexual contact or medical procedures involving needles. While hepatitis B is not exclusive to travel, these vaccines cater to the needs of individuals seeking protection against this virus while away from their home country.
Breakup by Region:
Asia Pacific
North America
Europe
Middle East and Africa
Latin America
North America leads the market, accounting for the largest travel vaccines market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. According to the report, North America accounted for the largest market share due to the high level of outbound international travel from the United States and Canada. The region has a strong emphasis on health and safety during travel, and travelers are well-informed about the importance of vaccinations. Additionally, government recommendations and regulations, including those set by the Centers for Disease Control and Prevention (CDC) in the United States, play a significant role in promoting the uptake of travel vaccines. North America also benefits from a well-established healthcare infrastructure and a robust pharmaceutical industry, making travel vaccines readily accessible to the population.
Europe is another substantial market for travel vaccines. With its diverse range of destinations and a large number of international travelers, European countries have a strong demand for travel vaccinations. The European Union is establishing guidelines for travelers, recommending vaccinations based on destination and health history. European travelers tend to be proactive in seeking pre-travel healthcare advice, contributing to the growth of the market in the region.
The Asia Pacific region is experiencing rapid growth in the market due to a rise in outbound tourism and business travel. As economies in the region are expanding, more individuals have the means and desire to explore international destinations. This is resulting in a heightened awareness of travel-related health risks, catalyzing the demand for travel vaccines. Moreover, some countries are becoming popular tourist destinations, leading to an increase in inbound travelers who also require vaccinations.
The Middle East and Africa region also contribute to the market. This segment is driven by both outbound tourism and inbound travelers, as the region hosts various cultural, religious, and business events. Vaccinations are often mandated for individuals traveling to Mecca for Hajj or Umrah, further propelling the market growth. In addition, the presence of diseases like yellow fever and malaria underscores the importance of vaccinations for travelers.
Latin America is another growing market for travel vaccines, driven by increasing outbound travel from countries like Brazil and Mexico. Travelers from these regions often explore destinations within South America, North America, and Europe, necessitating vaccinations for disease prevention.
Leading Key Players in the Travel Vaccines Industry:
Key players in the market are actively engaged in several strategic initiatives. They are investing in research and development (R&D) activities to expand their vaccine portfolios, addressing emerging travel-related health risks and enhancing existing efficacy of vaccines. These companies are also focusing on increasing their global distribution networks to ensure accessibility to travel vaccines in diverse regions. Furthermore, they collaborate with healthcare providers, government agencies, and international health organizations to promote vaccination awareness and education among travelers. Additionally, pharmaceutical firms are exploring innovative vaccine delivery methods, such as oral or patch-based vaccines, to improve convenience and compliance for travelers. Overall, key players are dedicated to advancing the field of travel vaccines to meet the evolving needs of global travelers effectively.
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:
GlaxoSmithKline Pharmaceuticals Limited
Sanofi Pasteur
Merck & Co., Inc.
Novartis AG
Pfizer Inc.
ALK-Abelló A/S
Bavarian Nordic A/S
Crucell (Subsidiary of Johnson & Johnson)
CSL Limited
AstraZeneca PLC
Altimmune, Inc.
Abbott Laboratories
Hoffmann-La Roche, Inc.
Key Questions Answered in This Report
1. What is the size of the global travel vaccines market in 2024?
2. What is the expected growth rate of the global travel vaccines market during 2025-2033?
3. What are the key factors driving the global travel vaccines market?
4. What has been the impact of COVID-19 on the global travel vaccines market?
5. What is the breakup of the global travel vaccines market based on the composition?
6. What is the breakup of the global travel vaccines market based on the disease?
7. What are the key regions in the global travel vaccines market?
8. Who are the key companies/players in the global travel vaccines market?
